序号 |
CAS |
半岛bd体育手机客户端 名称 |
规格 |
包装 |
参考价格 |
1 |
13832-70-7 |
Stearyl glycyrrhetinate |
≥98% |
50mg, 100mg, 250mg |
询价 |
2 |
|
TCMDC-135051 TFA |
≥98% |
50mg, 100mg, 250mg |
询价 |
3 |
2170136-65-7 |
GSK-3484862 HCl |
≥98% |
|
询价 |
4 |
|
BCN-PEG1-Val-Cit-PABC-OH |
≥98% |
50mg, 100mg, 250mg |
询价 |
5 |
1881221-47-1 |
BCN-PEG4-acid |
≥98% |
50mg, 100mg, 250mg |
询价 |
6 |
|
HS-PEG7-CH2CH2NH2 |
≥98% |
50mg, 100mg, 250mg |
询价 |
7 |
|
Carboxyrhodamine 110-PEG4-DBCO |
≥98% |
50mg, 100mg, 250mg |
询价 |
8 |
|
NHS-PEG4-(m-PEG12)3-ester |
≥98% |
50mg, 100mg, 250mg |
询价 |
9 |
|
Propargyl-PEG12-methane |
≥98% |
50mg, 100mg, 250mg |
询价 |
10 |
1620461-89-3 |
m-PEG12-Br |
≥98% |
50mg, 100mg, 250mg |
询价 |
11 |
|
Thiol-PEG9-alcohol |
≥98% |
50mg, 100mg, 250mg |
询价 |
12 |
|
m-PEG-Tresyl(MW 5000) |
≥98% |
50mg, 100mg, 250mg |
询价 |
13 |
|
Amino-PEG12-CH2COOH |
≥98% |
50mg, 100mg, 250mg |
询价 |
14 |
1841134-72-2 |
BCN-exo-PEG3-NH2 |
≥98% |
50mg, 100mg, 250mg |
询价 |
15 |
1258596-39-2 |
m-PEG11-Br |
≥98% |
50mg, 100mg, 250mg |
询价 |
16 |
|
Biotin-PEG3-aldehyde |
≥98% |
50mg, 100mg, 250mg |
询价 |
17 |
|
NH2-PEG5-C1-Boc |
≥98% |
50mg, 100mg, 250mg |
询价 |
18 |
|
Mal-PEG-Succinimidyl Valerate(MW 20000) |
≥98% |
50mg, 100mg, 250mg |
询价 |
19 |
|
N3-PEG24-Hydrazide |
≥98% |
50mg, 100mg, 250mg |
询价 |
20 |
|
IKKγNBD Inhibitory Peptide TFA |
≥98% |
50mg, 100mg, 250mg |
询价 |
21 |
156792-25-5 |
(R)-SCH 42495 |
≥98% |
50mg, 100mg, 250mg |
询价 |
22 |
490-78-8 |
2,5-Dihydroxyacetophenone |
≥98% |
50mg, 100mg, 250mg |
询价 |
23 |
4135-11-9 |
Polymyxin B1 |
≥98% |
|
询价 |
24 |
1571-87-5 |
GABAA receptor agent 1 |
≥98% |
50mg, 100mg, 250mg |
询价 |
25 |
135383-62-9 |
N-Boc-Val-Dil-Dap-Doe |
≥98% |
|
询价 |
26 |
1202764-53-1 |
B022 |
≥98% |
|
询价 |
27 |
72503-80-1 |
Sannamycin B |
≥98% |
|
询价 |
28 |
192329-42-3 |
Prinomastat |
≥98% |
|
询价 |
29 |
59435-08-4 |
PYR-5084 |
≥98% |
|
询价 |
30 |
75272-39-8 |
Nemonapride |
≥98% |
|
询价 |
31 |
93673-82-6 |
Hydroxy-PEG1-methyl ester |
≥98% |
|
询价 |
32 |
135637-46-6 |
Atizoram |
≥98% |
|
询价 |
33 |
1362-42-1 |
Absinthin |
≥98% |
|
询价 |
34 |
154355-75-6 |
Atreleuton racemic |
≥98% |
|
询价 |
35 |
1388658-04-5 |
BDM31827 |
≥98% |
|
询价 |
36 |
74-31-7 |
p-Phenylenediamine,N,N'-diphenyl- |
≥98% |
|
询价 |
37 |
57460-41-0 |
Talinolol |
≥98% |
|
询价 |
38 |
55643-87-3 |
ADD-17014 |
≥98% |
|
询价 |
39 |
55830-67-6 |
Rovicurt |
≥98% |
|
询价 |
40 |
141429-64-3 |
SB 201823-A |
≥98% |
|
询价 |
41 |
800-22-6 |
Chloracyzine |
≥98% |
|
询价 |
42 |
1354812-99-9 |
RO5527239 |
≥98% |
|
询价 |
43 |
92-26-2 |
Acridine Yellow |
≥98% |
|
询价 |
44 |
90-39-1 |
(-)-Sparteine |
≥98% |
|
询价 |
45 |
153804-05-8 |
Pratosartan |
≥98% |
|
询价 |
46 |
3653-50-7 |
Acetic acid,dichloro-,2-(2,2-dichloro-N-(p-(methylsulfonyl)benzyl)acetamido)ethyl ester |
≥98% |
|
询价 |
47 |
747412-64-2 |
Luminespib mesylate |
≥98% |
|
询价 |
48 |
1370540-16-1 |
Atelocantel |
≥98% |
|
询价 |
49 |
2107273-80-1 |
N-(m-PEG4)-N'-(Acid-PEG3)-benzothiazole Cy5 |
≥98% |
50mg, 100mg, 250mg |
询价 |
50 |
|
DBCO-NHCO-PEG2-amine |
≥98% |
50mg, 100mg, 250mg |
询价 |
51 |
1243536-56-2 |
Azido-PEG6-azide |
≥98% |
50mg, 100mg, 250mg |
询价 |
52 |
|
HO-PEG12-CH2COOH |
≥98% |
50mg, 100mg, 250mg |
询价 |
53 |
|
1-(Isopropylthio)-2,3,4,6-tetra-o-Ac-beta-D-glucosylpyranose |
≥98% |
50mg, 100mg, 250mg |
询价 |
54 |
1422540-91-7 |
Propargyl-PEG6-SH |
≥98% |
50mg, 100mg, 250mg |
询价 |
55 |
|
HS-PEG10-CH2CH2COOH |
≥98% |
50mg, 100mg, 250mg |
询价 |
56 |
|
Fmoc-NH-PEG11-CH2CH2COOH |
≥98% |
50mg, 100mg, 250mg |
询价 |
57 |
|
APN-PEG4-BCN |
≥98% |
50mg, 100mg, 250mg |
询价 |
58 |
39637-78-0 |
(R)-TCO-OH |
≥98% |
50mg, 100mg, 250mg |
询价 |
59 |
|
DBCO-mPEG(MW 2kDa) |
≥98% |
50mg, 100mg, 250mg |
询价 |
60 |
1171122-72-7 |
Azido-PEG9-azide |
≥98% |
50mg, 100mg, 250mg |
询价 |